139 related articles for article (PubMed ID: 21342047)
1. Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence.
Daniele G; Giordano P; De Luca A; Piccirillo MC; Di Maio M; Del Giudice A; De Feo G; Bryce J; Lamura L; Vecchione A; Normanno N; Perrone F
Expert Rev Anticancer Ther; 2011 Feb; 11(2):299-307. PubMed ID: 21342047
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
Aft R
Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
Freedman OC; Amir E; Clemons MJ
Crit Rev Oncol Hematol; 2009 Oct; 72(1):56-64. PubMed ID: 19307138
[TBL] [Abstract][Full Text] [Related]
5. Potential anticancer properties of bisphosphonates.
Neville-Webbe HL; Gnant M; Coleman RE
Semin Oncol; 2010 Jun; 37 Suppl 1():S53-65. PubMed ID: 20682373
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects and anticancer applications of bisphosphonates.
Morgan G; Lipton A
Semin Oncol; 2010 Oct; 37 Suppl 2():S30-40. PubMed ID: 21111246
[TBL] [Abstract][Full Text] [Related]
7. Are bisphosphonates the suitable anticancer drugs for the elderly?
Santini D; Fratto ME; Galluzzo S; Vincenzi B; Tonini G
Crit Rev Oncol Hematol; 2009 Jan; 69(1):83-94. PubMed ID: 18692400
[TBL] [Abstract][Full Text] [Related]
8. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
Lipton A
Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for breast cancer: questions answered, questions remaining.
Layman R; Olson K; Van Poznak C
Hematol Oncol Clin North Am; 2007 Apr; 21(2):341-67. PubMed ID: 17512453
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates' antitumor activity: an unravelled side of a multifaceted drug class.
Clézardin P
Bone; 2011 Jan; 48(1):71-9. PubMed ID: 20655399
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
Kanakis I; Kousidou OCh; Karamanos NK
In Vivo; 2005; 19(1):311-8. PubMed ID: 15796191
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in preclinical bone oncology.
Clézardin P; Benzaïd I; Croucher PI
Bone; 2011 Jul; 49(1):66-70. PubMed ID: 21145441
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates: ready for use as adjuvant therapy of breast cancer?
Theriault RL
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):61-6. PubMed ID: 19934757
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant bisphosphonate treatment for breast cancer: why did something so elegant become so complicated?
Clemons M; Russell K; Costa L; Addison CL
Breast Cancer Res Treat; 2012 Jul; 134(2):453-7. PubMed ID: 22562125
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).
Diel IJ; Mundy GR
Br J Cancer; 2000 Apr; 82(8):1381-6. PubMed ID: 10780514
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: new therapeutic agents for the treatment of bone tumors.
Heymann D; Ory B; Gouin F; Green JR; Rédini F
Trends Mol Med; 2004 Jul; 10(7):337-43. PubMed ID: 15242682
[TBL] [Abstract][Full Text] [Related]
17. The antitumor potential of bisphosphonates.
Clézardin P
Semin Oncol; 2002 Dec; 29(6 Suppl 21):33-42. PubMed ID: 12584693
[TBL] [Abstract][Full Text] [Related]
18. Toward new horizons: the future of bisphosphonate therapy.
Lipton A
Oncologist; 2004; 9 Suppl 4():38-47. PubMed ID: 15459428
[TBL] [Abstract][Full Text] [Related]
19. New results from the use of bisphosphonates in cancer patients.
Coleman R; Gnant M
Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]